Incannex Healthcare Inc.
IXHL
$0.45
$0.0512.68%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -86.05% | 616.67% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -86.05% | 616.67% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -86.05% | 616.67% | -- | -- | -- |
| SG&A Expenses | -16.07% | -23.51% | 3.16% | 36.67% | 106.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.43% | 18.80% | 26.25% | 58.40% | 99.54% |
| Operating Income | 1.11% | -18.42% | -25.65% | -57.70% | -98.80% |
| Income Before Tax | -107.03% | -154.41% | -34.26% | -73.40% | -103.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.76% | -154.00% | -34.45% | -73.61% | -103.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.76% | -154.00% | -34.45% | -73.61% | -103.29% |
| EBIT | 1.11% | -18.42% | -25.65% | -57.70% | -98.80% |
| EBITDA | 1.70% | -17.52% | -24.05% | -56.13% | -98.12% |
| EPS Basic | 32.88% | -7.83% | -20.02% | -62.15% | -93.11% |
| Normalized Basic EPS | 36.83% | -3.02% | -14.87% | -61.93% | -92.88% |
| EPS Diluted | 32.88% | -7.83% | -20.02% | -62.15% | -93.11% |
| Normalized Diluted EPS | 36.83% | -3.02% | -14.87% | -61.93% | -92.88% |
| Average Basic Shares Outstanding | 548.33% | 113.43% | 13.30% | 7.38% | 5.41% |
| Average Diluted Shares Outstanding | 548.33% | 113.43% | 13.30% | 7.38% | 5.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |